Once thought to be purely an endocrine disorder, a more modern understanding of insulin resistance and glycemic regulation has revealed that prediabetes, type 1 and type 2 diabetes are hugely related to cardiometabolic disease and its many comorbidities. As the understanding of how diabetes is related to conditions like obesity and heart failure grows, more therapeutic targets are being identified, showing promise for many new treatments.
Expert Highlights and Perspectives
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
A Dr. Sarah Hallberg Legacy Course
This 4.5 hour, virtual webcast honored the late Dr. Sarah Hallberg by covering insights and practical strategies for the reversal of type 2 diabetes, with a focus on the role of low-carbohydrate interventions in this setting. Recorded on February 24, 2024.
-
Welcome and Introduction
Nina Teicholz, PhD & Ron Krauss, MD -
Definition & Pathophysiology of Type 2 Diabetes
Ben Bikman, PhD -
What Do We Mean by T2DM Reversal?
Nina Teicholz, PhD; Sarah Hallberg, DO, MS -
Metabolic Basis for Low-carbohydrate and Ketogenic Diets
Jeff Volek, PhD -
Clinical Trial Evidence for Type 2 Diabetes Reversal Through Dietary Approaches
Laura Saslow, PhD -
Practical Approaches to Implement and Maintain a Low-Carbohydrate Diet
Tony Hampton, MD; Ronesh Sinha, MD -
Patient Cases, Panel Discussion, and Audience Q&A
Moderators: Nina Teicholz, PhD & Ron Krauss, MD
Panelists: All faculty
MD
DUAL GLP-1/GIP AGONISTS: ARE THEY THE NEXT BIG THING IN DIABETES TREATMENT
(Recorded April 2022)
MD
HOW CAN WE CONVERGE THE GLUCOCENTRIC AND CARDIO-RENAL RISK MANAGEMENT IN DIABETES PATIENTS
(Recorded April 2022)
MD
MD
MD, PhD
MD, PhD
MD
MD
MD
MD
MD
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
A Dr. Sarah Hallberg Legacy Course
This 4.5 hour, virtual webcast honored the late Dr. Sarah Hallberg by covering insights and practical strategies for the reversal of type 2 diabetes, with a focus on the role of low-carbohydrate interventions in this setting. Recorded on February 24, 2024.
-
Welcome and Introduction
Nina Teicholz, PhD & Ron Krauss, MD -
Definition & Pathophysiology of Type 2 Diabetes
Ben Bikman, PhD -
What Do We Mean by T2DM Reversal?
Nina Teicholz, PhD; Sarah Hallberg, DO, MS -
Metabolic Basis for Low-carbohydrate and Ketogenic Diets
Jeff Volek, PhD -
Clinical Trial Evidence for Type 2 Diabetes Reversal Through Dietary Approaches
Laura Saslow, PhD -
Practical Approaches to Implement and Maintain a Low-Carbohydrate Diet
Tony Hampton, MD; Ronesh Sinha, MD -
Patient Cases, Panel Discussion, and Audience Q&A
Moderators: Nina Teicholz, PhD & Ron Krauss, MD
Panelists: All faculty
News Digest
Care in (un)Common Settings with Dr. Keith C. Ferdinand
Updated 2023 ADA Standards of Care
The new ADA guideline contains updated guidance for clinicians who care for the estimated 100 million patients in the U.S. with prediabetes or diabetes.
Identifying and Treating Severe Hypoglycemia in Pediatric Patients with Diabetes
CMHC Presents at the 82nd Annual Scientific Sessions of ADA 2022 in New Orleans
Diabetes Insights and Updates with Dr. Anne Peters
Bariatric surgery improves diabetes remission, reduces cardiometabolic risk
The Price of Insulin: The Real Cost of Diabetes
Remembering Dr. Sarah Hallberg
Cardiometabolic Health Congress is saddened to learn that faculty Sarah Hallberg, DO, MS, passed away following a courageous battle with cancer.
Prediabetes: A Dangerous Precursor
article
Care Delivery Implementation
This clinical brief was developed from a session at the 17th Annual Cardiometabolic Health Congress (CMHC) presented by Irl B Hirsch, MD from the University
article
Cardiometabolic Disease
The experts behind Cardiometabolic Health Congress have identified 10 stories in cardiorenal medicine to watch in 2023.
article
Diabetes
Sanofi was the last of three pharmaceutical goliaths to announce they’d make good on their long-spoken promise to lower the price of their insulin.
CME/CE Activities
Drug Pipeline
Drug Pipeline Coming Soon
#C1E5E9
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
#C1E5E9
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
#C1E5E9
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Resources
American Diabetes Association –
2022 Standards of Medical Care
in Diabetes
Diabetes Technology – Standards of Medical Care in Diabetes – 2022
Pharmacologic Approaches to
Glycemic Treatment: Standards of Medical Care in Diabetes – 2022
AACE: 2021 Advances Diabetes Technology Guideline
AHA Scientific Statement: Comprehensive Management of Cardiovascular Risk Factors For Adults with Type 2 Diabetes
Why Should We Use CGM in Patients With Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration
